CAPTRUST Financial Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-3,574
Closed -$222K – 2709
2023
Q4
$222K Sell
3,574
-9
-0.3% -$503 ﹤0.01% 2319
2023
Q3
$201K Buy
+3,583
New +$202K ﹤0.01% 2293
2022
Q3
– Sell
-947
Closed -$54K – 4234
2022
Q2
$54K Buy
947
+241
+34% +$13.2K ﹤0.01% 2696
2022
Q1
$44K Buy
706
+277
+65% +$14.9K ﹤0.01% 2894
2021
Q4
$24K Buy
429
+93
+28% +$5.68K ﹤0.01% 3179
2021
Q3
$22K Hold
336
– – ﹤0.01% 3102
2021
Q2
$21K Hold
336
– – ﹤0.01% 3084
2021
Q1
$20K Buy
336
+226
+205% +$12.3K ﹤0.01% 3011
2020
Q4
$5K Hold
110
– – ﹤0.01% 2877
2020
Q3
$6K Hold
110
– – ﹤0.01% 2492
2020
Q2
$4K Buy
+110
New +$3.79K ﹤0.01% 2467

Other funds holding AXNX

CAPTRUST Financial Advisors's AXNX Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 3,574 shares — an estimated $222K sold.

CAPTRUST Financial Advisors first reported a position in AXNX in Q2 2020 and held it in 11 quarters. The position peaked at $222K in Q4 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3,574 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $222K.
  • CAPTRUST Financial Advisors first reported a position in Axonics, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
  • CAPTRUST Financial Advisors's Axonics, Inc. Common Stock position peaked at $222K in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.